中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

51 records (took 0.03 seconds)

    FIBRATE COMPOUNDS HAVING PPAR AGONIST ACTIVITY
    34.
    发明申请
    FIBRATE COMPOUNDS HAVING PPAR AGONIST ACTIVITY 审中-公开
    具有PPAR激动剂活性的纤维化合物

    公开(公告)号：WO2006029075A8

    公开(公告)日：2007-04-26

    申请号：PCT/US2005031532

    申请日：2005-09-06

    Applicant: REDDYS LAB LTD DR ,  REDDYS LAB INC DR ,  DAS SAIBAL KUMAR ,  SINGH SUNIL KUMAR ,  MADHAVAN GURRAM RANGA ,  BHUNIYA DEBNATH ,  IQBAL JAVED ,  SHARMA SUDHIR KUMAR ,  CHAKRABARTI RANJAN

    Inventor： DAS SAIBAL KUMAR ,  SINGH SUNIL KUMAR ,  MADHAVAN GURRAM RANGA ,  BHUNIYA DEBNATH ,  IQBAL JAVED ,  SHARMA SUDHIR KUMAR ,  CHAKRABARTI RANJAN

    IPC: A61K31/519 ,  C07D487/02

    CPC classification number: C07D487/04 ,  C07D239/90

    Abstract: There are provided derivatives having PPAR agonist activity. The derivatives include compounds and/or their pharmaceutically acceptable salts; the compounds having the formula (I) wherein A has the structure (II) or (III); X is chosen from -CH 2 -, -O-, -NH-, and -S-; Y is chosen from -O-, -NH-, and -S-; Z, which may be located in any position of substitution, is hydrogen or halogen; R 1 and R 2 , which may be the same or different, are independently chosen from hydrogen and C 1 -C 8 alkyl, or R 1 and R 2 together form a carbocyclic ring having from 4 to 6 carbon atoms; R 3 is chosen from hydrogen and C 1 -C 8 alkyl; R 4 , R 5 , and R 6 , which may be the same or different, are independently chosen from hydrogen and C 1 -C 8 alkyl; and n is 1 to 6. Various embodiments and variants are provided. In accordance with other aspects, the invention also provides methods of producing a PPARa agonist activity in a mammal, the methods including administering to the mammal an effective amount of certain derivative(s) of the first aspect of the invention, a method of producing a PPARa agonist activity and a PPARa agonist activity in a mammal, the method including administering to the mammal an effective amount of certain derivative(s); and a pharmaceutical composition that includes the derivative(s) of the first aspect of the invention and one or more pharmaceutically-acceptable excipients. Various embodiments and variants are provided.

    Abstract translation: 提供了具有PPAR激动剂活性的衍生物。 衍生物包括化合物和/或其药学上可接受的盐; 其中A具有结构（II）或（III）的具有式（I）的化合物; X选自-CH 2 - ， - O - ， - NH-和-S-; Y选自-O - ， - NH-和-S-; 可以位于任何取代位置的Z是氢或卤素; R 1和R 2可以相同或不同，独立地选自氢和C 1 -C 8烷基， 烷基或R 1和R 2一起形成具有4至6个碳原子的碳环; R 3选自氢和C 1 -C 8烷基; R 3选自氢和C 1 -C 8烷基; R 4，R 5和R 6可以相同或不同，独立地选自氢和C 1 -C 4烷基， -C 8烷基; 并且n是1至6.提供了各种实施例和变体。 根据其它方面，本发明还提供了在哺乳动物中产生PPARα激动剂活性的方法，所述方法包括向哺乳动物施用有效量的本发明第一方面的某些衍生物，产生 PPARα激动剂活性和PPARα激动剂活性，所述方法包括给哺乳动物施用有效量的某些衍生物; 以及包含本发明第一方面的衍生物和一种或多种药学上可接受的赋形剂的药物组合物。 提供了各种实施例和变体。

    FIBRATE COMPOUNDS HAVING PPAR AGONIST ACTIVITY
    35.
    发明申请
    FIBRATE COMPOUNDS HAVING PPAR AGONIST ACTIVITY 审中-公开
    具有PPAR激动剂活性的纤维化合物

    公开(公告)号：WO2006029075A2

    公开(公告)日：2006-03-16

    申请号：PCT/US2005031532

    申请日：2005-09-06

    Applicant: REDDYS LAB LTD DR ,  REDDYS LAB LTD DR ,  DAS SAIBAL KUMAR ,  SINGH SUNIL KUMAR ,  MADHAVAN GURRAM RANGA ,  BHUNIYA DEBNATH ,  IQBAL JAVED ,  SHARMA SUDHIR KUMAR ,  CHAKRABARTI RANJAN

    Inventor： DAS SAIBAL KUMAR ,  SINGH SUNIL KUMAR ,  MADHAVAN GURRAM RANGA ,  BHUNIYA DEBNATH ,  IQBAL JAVED ,  SHARMA SUDHIR KUMAR ,  CHAKRABARTI RANJAN

    IPC: A61K31/519 ,  C07D487/02

    CPC classification number: C07D487/04 ,  C07D239/90

    Abstract: There are provided derivatives having PPAR agonist activity. The derivatives include compounds and/or their pharmaceutically acceptable salts; the compounds having the formula (I) wherein A has the structure (II) or (III); X is chosen from -CH 2 -, -O-, -NH-, and -S-; Y is chosen from -O-, -NH-, and -S-; Z, which may be located in any position of substitution, is hydrogen or halogen; R 1 and R 2 , which may be the same or different, are independently chosen from hydrogen and C 1 -C 8 alkyl, or R 1 and R 2 together form a carbocyclic ring having from 4 to 6 carbon atoms; R 3 is chosen from hydrogen and C 1 -C 8 alkyl; R 4 , R 5 , and R 6 , which may be the same or different, are independently chosen from hydrogen and C 1 -C 8 alkyl; and n is 1 to 6. Various embodiments and variants are provided. In accordance with other aspects, the invention also provides methods of producing a PPARa agonist activity in a mammal, the methods including administering to the mammal an effective amount of certain derivative(s) of the first aspect of the invention, a method of producing a PPARa agonist activity and a PPARa agonist activity in a mammal, the method including administering to the mammal an effective amount of certain derivative(s); and a pharmaceutical composition that includes the derivative(s) of the first aspect of the invention and one or more pharmaceutically-acceptable excipients. Various embodiments and variants are provided.

    Abstract translation: 提供具有PPAR激动剂活性的衍生物。 衍生物包括化合物和/或其药学上可接受的盐; 具有式（I）的化合物其中A具有结构（II）或（III）; X选自-CH 2 - ， - O - ， - N - 和-S-; Y选自-O - ， - NH-和-S-; 可以位于任何取代位置的Z是氢或卤素; R 1和R 2可以相同或不同，独立地选自氢和C 1 -C 8烷基， 或者R 1和R 2一起形成具有4至6个碳原子的碳环; R 3选自氢和C 1 -C 8烷基; R 4，R 5，R 5和R 6可以相同或不同，独立地选自氢和C 1 C 8 -C 14烷基; 并且n为1至6.提供了各种实施方案和变体。 根据其它方面，本发明还提供了在哺乳动物中产生PPARα激动剂活性的方法，所述方法包括向哺乳动物施用有效量的本发明第一方面的某些衍生物， PPARα激动剂活性和PPARα激动剂活性，所述方法包括向哺乳动物施用有效量的某些衍生物; 和包含本发明第一方面的衍生物和一种或多种药学上可接受的赋形剂的药物组合物。 提供了各种实施例和变型。

Patent Agency Ranking